Panel-based estimates of tumor mutational burden: characterizing unknown unknowns
نویسندگان
چکیده
منابع مشابه
Unmeasured anions: the unknown unknowns
Evidence is emerging that elevated concentrations of the intermediates of the citric acid cycle may contribute to unmeasured anions in critical illness. Both the anion gap and the strong ion gap are used as scanning tools for recognition of these anions. The mechanisms underlying these elevations and their significance require further clarification.
متن کاملDiscovering Unknown Unknowns of Predictive Models
Predictive models are widely used in domains ranging from judiciary and healthcare to autonomous driving. As we increasingly rely on these models for high-stakes decisions, identifying and characterizing their unexpected failures in the real world is critical. We categorize errors of a predictive model as: known unknowns and unknown unknowns [3]. Known unknowns are those data points for which t...
متن کاملData Interoperability of Whole Exome Sequencing (WES) Based Mutational Burden Estimates from Different Laboratories
Immune checkpoint inhibitors, which unleash a patient's own T cells to kill tumors, are revolutionizing cancer treatment. Several independent studies suggest that higher non-synonymous mutational burden assessed by whole exome sequencing (WES) in tumors is associated with improved objective response, durable clinical benefit, and progression-free survival in immune checkpoint inhibitors treatme...
متن کاملA Coverage-Based Utility Model for Identifying Unknown Unknowns
A classifier’s low confidence in prediction is often indicative of whether its prediction will be wrong; in this case, inputs are called known unknowns. In contrast, unknown unknowns (UUs) are inputs on which a classifier makes a high confidence mistake. Identifying UUs is especially important in safety-critical domains like medicine (diagnosis) and law (recidivism prediction). Previous work by...
متن کاملCharting the "unknown unknowns" of cancer progression.
Integrated computational and experimental strategies reveal previously unknown regulatory programs underlying metastatic disease.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2019
ISSN: 0923-7534
DOI: 10.1093/annonc/mdz234